Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514539 · ClinicalTrials.gov registry record · NA
Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk
A NA study of Maternal Obesity Syndrome, sponsored by University of Wyoming.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT01514539: Completed NA study of Maternal Obesity Syndrome, sponsored by University of Wyoming.
NCT01514539 is a NA study of Maternal Obesity Syndrome that has completed, run by University of Wyoming. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01514539, a NA study of Maternal Obesity Syndrome, has completed, sponsored by University of Wyoming.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk Studies suggest that childbearing is an important contributor to the development of obesity in many women and that breastfeeding may be protective. Ghrelin and peptide YY (PYY) are gut hormones involved in appetite regulation and energy homeostasis and are biological neuroendocrine signals that potentially affect body weight and adiposity/
Primary Outcome
Biomedical Research Study that will provide information on reducing maternal obesity.
Conditions Studied
Interventions
- OTHER cross-sectional
Study Locations (1)
Wyoming
- Nutritional and Exercise Lab University of Wyoming - Laramie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01514539 record still lists
NCT01514539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Maternal Obesity Syndrome appearing as the primary indexed condition, and to 1 intervention - of which cross-sectional is the first listed.
NCT01514539 reports a single indexed study location in Wyoming.
Frequently Asked Questions
What is clinical trial NCT01514539 about?
NCT01514539 is a clinical study titled "Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk". Hormonal Regulation of Postpartum Weight and Presence of Gut Peptides in Human Milk Studies suggest that childbearing is an important contributor to the development of obesity in many women and that breastfeeding may be protective. Ghrelin and peptide YY (PYY) are gut hormones involved in appetite ...
What is the current status of trial NCT01514539?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2009-08. Estimated completion is 2014-04.
What conditions does trial NCT01514539 study?
This clinical trial studies the following conditions: Maternal Obesity Syndrome.
What interventions are being tested in trial NCT01514539?
The interventions under investigation include: cross-sectional (OTHER).
Who is sponsoring clinical trial NCT01514539?
This trial is sponsored by University of Wyoming, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01514539 being conducted?
This trial has 1 study location across Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01514539's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia